LivaNova (LIVN) Gross Margin Growth (3y) (2019 - 2026)

LivaNova (LIVN) Gross Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.20 Bn 175.91 Bn 6.27 Bn 63.00
2 Stryker 128.87 Bn 125.99 Bn 3.81 Bn 17.00
3 Medtronic 108.88 Bn 99.66 Bn 6.41 Bn 21.00
4 Boston Scientific 68.33 Bn 66.87 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 47.31 Bn 43.64 Bn 1.29 Bn -324.00
6 Dexcom 28.65 Bn 27.53 Bn 750.30 Mn 56.00
7 GE HealthCare Technologies 28.40 Bn 26.11 Bn 1.98 Bn -164.00
8 Smith & Nephew 26.97 Bn 26.40 Bn - -
9 Koninklijke Philips 25.55 Bn 22.42 Bn 2.07 Bn 311.00
10 LivaNova 4.35 Bn 3.81 Bn 243.75 Mn 120.00

Historic Data

Download Data
DateValue
Mar 31, 2026 120.00
Dec 31, 2025 -33.00
Sep 30, 2025 78.00
Jun 30, 2025 -474.00
Mar 31, 2025 -188.00
Dec 31, 2024 -806.00
Sep 30, 2024 287.00
Jun 30, 2024 231.00
Mar 31, 2024 291.00
Dec 31, 2023 -557.00
Sep 30, 2023 906.00
Jun 30, 2023 672.00
Mar 31, 2023 -211.00
Dec 31, 2022 677.00
Sep 30, 2022 -27.00
Jun 30, 2022 -43.00
Mar 31, 2022 373.00
Dec 31, 2021 511.00
Sep 30, 2021 253.00
Jun 30, 2021 -233.00